DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
1496
CARBIDOPA; LEVODOPA
4
Combination
Approved
OTHER
ENTERAL; ORAL
Unknown
Unknown
CARBIDOPA; LEVODOPA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CEFADROXIL/CEFADROXIL HEMIHYDRATE
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
CEFADROXIL/CEFADROXIL HEMIHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CEFTIBUTEN DIHYDRATE
4
Small molecule
Approved
ENT; IMMUNE SYSTEM; OTHER; RESPIRATORY
ORAL
Unknown
Unknown
CEFTIBUTEN DIHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CEFTRIAXONE SODIUM; LIDOCAINE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
CEFTRIAXONE SODIUM; LIDOCAINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CETYL ALCOHOL; COLFOSCERIL PALMITATE; TYLOXAPOL
4
Combination
Approved
OTHER
INTRATRACHEAL
Unknown
Unknown
CETYL ALCOHOL; COLFOSCERIL PALMITATE; TYLOXAPOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORAMPHENICOL; DESOXYRIBONUCLEASE; FIBRINOLYSIN
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
CHLORAMPHENICOL; DESOXYRIBONUCLEASE; FIBRINOLYSIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORAMPHENICOL; HYDROCORTISONE ACETATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
CHLORAMPHENICOL; HYDROCORTISONE ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORAMPHENICOL; HYDROCORTISONE ACETATE; POLYMYXIN B SULFATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
CHLORAMPHENICOL; HYDROCORTISONE ACETATE; POLYMYXIN B SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORAMPHENICOL; POLYMYXIN B SULFATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
CHLORAMPHENICOL; POLYMYXIN B SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORAMPHENICOL; PREDNISOLONE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
CHLORAMPHENICOL; PREDNISOLONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORDIAZEPOXIDE; ESTROGENS, ESTERIFIED
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORDIAZEPOXIDE; ESTROGENS, ESTERIFIED
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORMERODRIN HG-197
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
CHLORMERODRIN HG-197
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLOROQUINE PHOSPHATE; PRIMAQUINE PHOSPHATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLOROQUINE PHOSPHATE; PRIMAQUINE PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLOROTHIAZIDE; METHYLDOPA
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLOROTHIAZIDE; METHYLDOPA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLOROTHIAZIDE; RESERPINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLOROTHIAZIDE; RESERPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORPHENIRAMINE POLISTIREX; PHENYLPROPANOLAMINE POLISTIREX
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORPHENIRAMINE POLISTIREX; PHENYLPROPANOLAMINE POLISTIREX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORTHALIDONE; METOPROLOL TARTRATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORTHALIDONE; METOPROLOL TARTRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORTHALIDONE; RESERPINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORTHALIDONE; RESERPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHROMIC PHOSPHATE P-32
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
CHROMIC PHOSPHATE P-32
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CILASTATIN SODIUM; IMIPENEM
4
Combination
Approved
OTHER
INJECTION; INTRAMUSCULAR; INTRAVENOUS
Unknown
Unknown
CILASTATIN SODIUM; IMIPENEM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CIPROFLOXACIN; DEXAMETHASONE
4
Combination
Approved
OTHER
OTIC
Unknown
Unknown
CIPROFLOXACIN; DEXAMETHASONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE
4
Combination
Approved
OTHER
OTIC
Unknown
Unknown
CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
29
30
31
32
33
34
35
…
42
43
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA